Page results
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
This page offers ways you can help us to prevent infection and make your babies safer.
-
Overall, most women (over 90%) spontaneously give birth to their baby after 37 weeks of pregnancy, called term delivery. Approximately 10%, or 1 in 10 women spontaneously give birth to their baby…
-
This page has been written to provide information to those women who choose to decline a blood transfusion or blood products. It is important for you to know that your decision is respected and that…
File results
-
FOI/2024/0666 - Non-emergency patient transport services (NEPTS) and pathology specimen courier services
-
FOI/2024/0650 - Framework used for Radiology Information System (RIS)
-
FOI/2024/0653 - Sterile services/ decontamination units
-
FOI/2024/0659 - Treatment of cancers; breast/ prostate/ ovarian and endometrial
-
FOI/2024/0660 - Bariatric patient equipment spend/ contract/ supplier
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0664 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0669 - LIMS and digital pathology systems
-
FOI/2024/0681 - Postoperative infections associated with cataract surgery 2019/20-2022/23
-
FOI/2024/0673 - A&E visits/ treatment for rings stuck on fingers - May 2023-May 2024